Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Chemours (CC) over the last 11 years, with Q3 2025 value amounting to $613.0 million.

  • Chemours' Cash & Equivalents rose 285.23% to $613.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $613.0 million, marking a year-over-year increase of 285.23%. This contributed to the annual value of $713.0 million for FY2024, which is 4073.15% down from last year.
  • Latest data reveals that Chemours reported Cash & Equivalents of $613.0 million as of Q3 2025, which was up 285.23% from $502.0 million recorded in Q2 2025.
  • Chemours' Cash & Equivalents' 5-year high stood at $1.5 billion during Q4 2021, with a 5-year trough of $464.0 million in Q1 2025.
  • Over the past 5 years, Chemours' median Cash & Equivalents value was $852.0 million (recorded in 2023), while the average stood at $902.0 million.
  • Per our database at Business Quant, Chemours' Cash & Equivalents surged by 4117.65% in 2021 and then crashed by 4086.54% in 2023.
  • Quarter analysis of 5 years shows Chemours' Cash & Equivalents stood at $1.5 billion in 2021, then decreased by 24.05% to $1.1 billion in 2022, then grew by 9.17% to $1.2 billion in 2023, then plummeted by 40.73% to $713.0 million in 2024, then fell by 14.03% to $613.0 million in 2025.
  • Its last three reported values are $613.0 million in Q3 2025, $502.0 million for Q2 2025, and $464.0 million during Q1 2025.